Cargando…

ERK and AKT phosphorylation status in lung cancer and emphysema using nanocapillary isoelectric focusing

BACKGROUND: Emphysema is an independent risk factor for the development of lung cancer in smokers. Activation of oncogenic signalling proteins AKT and ERK by phosphorylation has an established role in the development of lung cancer and has also been implicated in the pathogenesis of emphysema. The a...

Descripción completa

Detalles Bibliográficos
Autores principales: Crosbie, Philip A J, Crosbie, Emma J, Aspinall-O'Dea, Mark, Walker, Michael, Harrison, Rebecca, Pernemalm, Maria, Shah, Rajesh, Joseph, Leena, Booton, Richard, Pierce, Andrew, Whetton, Anthony D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762086/
https://www.ncbi.nlm.nih.gov/pubmed/26918193
http://dx.doi.org/10.1136/bmjresp-2015-000114
_version_ 1782417054936072192
author Crosbie, Philip A J
Crosbie, Emma J
Aspinall-O'Dea, Mark
Walker, Michael
Harrison, Rebecca
Pernemalm, Maria
Shah, Rajesh
Joseph, Leena
Booton, Richard
Pierce, Andrew
Whetton, Anthony D
author_facet Crosbie, Philip A J
Crosbie, Emma J
Aspinall-O'Dea, Mark
Walker, Michael
Harrison, Rebecca
Pernemalm, Maria
Shah, Rajesh
Joseph, Leena
Booton, Richard
Pierce, Andrew
Whetton, Anthony D
author_sort Crosbie, Philip A J
collection PubMed
description BACKGROUND: Emphysema is an independent risk factor for the development of lung cancer in smokers. Activation of oncogenic signalling proteins AKT and ERK by phosphorylation has an established role in the development of lung cancer and has also been implicated in the pathogenesis of emphysema. The aim of this study was to compare the protein level and phosphorylation status of AKT and ERK in paired lung cancer and emphysema tissue using a highly sensitive phosphoprotein analysis approach. METHODS: An antibody-based, nanocapillary isoelectric focusing (cIEF) assay was used to determine the relative quantities and phosphorylation status of AKT and ERK in tumour and matched lung tissue from patients, with or without evidence of emphysema, undergoing curative resection for non-small cell lung cancer. RESULTS: 20 patients with adenocarcinoma (n=9) or squamous cell carcinoma (n=11) of the lung were included (mean age 67.3 years (SD 7.5, range 47–80 years)), 12 were men and all were current (n=10) or former smokers (n=10). Paired macroscopically normal lung tissue was either histologically normal (n=7) or showed emphysema (n=13). Total and phosphorylated AKT levels were fourfold (p=0.0001) and fivefold (p=0.001) higher in tumour compared with matched lung, respectively. There was no correlation with tumour histology, stage or differentiation; however, total AKT signal in tumour was significantly correlated with fluorodeoxyglucose avidity on positron emission tomography-CT scan (r=0.53, p=0.035). Total ERK was not differentially expressed, but doubly phosphorylated (activated) ERK was threefold higher in emphysema (23.5%, SD 9.2) than either matched tumour (8.8%, SD 8.6) or normal lung tissue (8.3%, SD 9.0) and correlated with the histological severity of emphysema (p=0.005). CONCLUSIONS: cIEF offers opportunities for quantifying subtle shifts in the phosphorylation status of oncoproteins in nanogram amounts of lung tissue. ERK activation is a feature of emphysema.
format Online
Article
Text
id pubmed-4762086
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-47620862016-02-25 ERK and AKT phosphorylation status in lung cancer and emphysema using nanocapillary isoelectric focusing Crosbie, Philip A J Crosbie, Emma J Aspinall-O'Dea, Mark Walker, Michael Harrison, Rebecca Pernemalm, Maria Shah, Rajesh Joseph, Leena Booton, Richard Pierce, Andrew Whetton, Anthony D BMJ Open Respir Res Lung Cancer BACKGROUND: Emphysema is an independent risk factor for the development of lung cancer in smokers. Activation of oncogenic signalling proteins AKT and ERK by phosphorylation has an established role in the development of lung cancer and has also been implicated in the pathogenesis of emphysema. The aim of this study was to compare the protein level and phosphorylation status of AKT and ERK in paired lung cancer and emphysema tissue using a highly sensitive phosphoprotein analysis approach. METHODS: An antibody-based, nanocapillary isoelectric focusing (cIEF) assay was used to determine the relative quantities and phosphorylation status of AKT and ERK in tumour and matched lung tissue from patients, with or without evidence of emphysema, undergoing curative resection for non-small cell lung cancer. RESULTS: 20 patients with adenocarcinoma (n=9) or squamous cell carcinoma (n=11) of the lung were included (mean age 67.3 years (SD 7.5, range 47–80 years)), 12 were men and all were current (n=10) or former smokers (n=10). Paired macroscopically normal lung tissue was either histologically normal (n=7) or showed emphysema (n=13). Total and phosphorylated AKT levels were fourfold (p=0.0001) and fivefold (p=0.001) higher in tumour compared with matched lung, respectively. There was no correlation with tumour histology, stage or differentiation; however, total AKT signal in tumour was significantly correlated with fluorodeoxyglucose avidity on positron emission tomography-CT scan (r=0.53, p=0.035). Total ERK was not differentially expressed, but doubly phosphorylated (activated) ERK was threefold higher in emphysema (23.5%, SD 9.2) than either matched tumour (8.8%, SD 8.6) or normal lung tissue (8.3%, SD 9.0) and correlated with the histological severity of emphysema (p=0.005). CONCLUSIONS: cIEF offers opportunities for quantifying subtle shifts in the phosphorylation status of oncoproteins in nanogram amounts of lung tissue. ERK activation is a feature of emphysema. BMJ Publishing Group 2016-02-17 /pmc/articles/PMC4762086/ /pubmed/26918193 http://dx.doi.org/10.1136/bmjresp-2015-000114 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/
spellingShingle Lung Cancer
Crosbie, Philip A J
Crosbie, Emma J
Aspinall-O'Dea, Mark
Walker, Michael
Harrison, Rebecca
Pernemalm, Maria
Shah, Rajesh
Joseph, Leena
Booton, Richard
Pierce, Andrew
Whetton, Anthony D
ERK and AKT phosphorylation status in lung cancer and emphysema using nanocapillary isoelectric focusing
title ERK and AKT phosphorylation status in lung cancer and emphysema using nanocapillary isoelectric focusing
title_full ERK and AKT phosphorylation status in lung cancer and emphysema using nanocapillary isoelectric focusing
title_fullStr ERK and AKT phosphorylation status in lung cancer and emphysema using nanocapillary isoelectric focusing
title_full_unstemmed ERK and AKT phosphorylation status in lung cancer and emphysema using nanocapillary isoelectric focusing
title_short ERK and AKT phosphorylation status in lung cancer and emphysema using nanocapillary isoelectric focusing
title_sort erk and akt phosphorylation status in lung cancer and emphysema using nanocapillary isoelectric focusing
topic Lung Cancer
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762086/
https://www.ncbi.nlm.nih.gov/pubmed/26918193
http://dx.doi.org/10.1136/bmjresp-2015-000114
work_keys_str_mv AT crosbiephilipaj erkandaktphosphorylationstatusinlungcancerandemphysemausingnanocapillaryisoelectricfocusing
AT crosbieemmaj erkandaktphosphorylationstatusinlungcancerandemphysemausingnanocapillaryisoelectricfocusing
AT aspinallodeamark erkandaktphosphorylationstatusinlungcancerandemphysemausingnanocapillaryisoelectricfocusing
AT walkermichael erkandaktphosphorylationstatusinlungcancerandemphysemausingnanocapillaryisoelectricfocusing
AT harrisonrebecca erkandaktphosphorylationstatusinlungcancerandemphysemausingnanocapillaryisoelectricfocusing
AT pernemalmmaria erkandaktphosphorylationstatusinlungcancerandemphysemausingnanocapillaryisoelectricfocusing
AT shahrajesh erkandaktphosphorylationstatusinlungcancerandemphysemausingnanocapillaryisoelectricfocusing
AT josephleena erkandaktphosphorylationstatusinlungcancerandemphysemausingnanocapillaryisoelectricfocusing
AT bootonrichard erkandaktphosphorylationstatusinlungcancerandemphysemausingnanocapillaryisoelectricfocusing
AT pierceandrew erkandaktphosphorylationstatusinlungcancerandemphysemausingnanocapillaryisoelectricfocusing
AT whettonanthonyd erkandaktphosphorylationstatusinlungcancerandemphysemausingnanocapillaryisoelectricfocusing